132 related articles for article (PubMed ID: 20698108)
1. Is the HSIL subclassification cytologically real and clinically justified?
Milicić-Juhas V; Pajtler M
Coll Antropol; 2010 Jun; 34(2):395-400. PubMed ID: 20698108
[TBL] [Abstract][Full Text] [Related]
2. The Bethesda System. A proposal for reporting abnormal cervical smears based on the reproducibility of cytopathologic diagnoses.
Sherman ME; Schiffman MH; Erozan YS; Wacholder S; Kurman RJ
Arch Pathol Lab Med; 1992 Nov; 116(11):1155-8. PubMed ID: 1444745
[TBL] [Abstract][Full Text] [Related]
3. Three-Tiered versus Two-Tiered Classification of Squamous Dysplasia in Cervical Cytology: Results of a Follow-Up Study.
Marquardt K; Ziemke P; Neumann K
Acta Cytol; 2019; 63(1):44-49. PubMed ID: 30517915
[TBL] [Abstract][Full Text] [Related]
4. Interobserver variability in cytologic subclassification of squamous intraepithelial lesions--the Bethesda System vs. World Health Organization classification.
Pajtler M; Audy-Jurković S; Milicić-Juhas V; Staklenac B; Pauzar B
Coll Antropol; 2006 Mar; 30(1):137-42. PubMed ID: 16617588
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up of women with atypical squamous cells of undetermined significance (ASCUS).
Emerson RE; Puzanov A; Brunnemer C; Younger C; Cramer H
Diagn Cytopathol; 2002 Sep; 27(3):153-7. PubMed ID: 12203862
[TBL] [Abstract][Full Text] [Related]
6. Biological behaviour of moderate dysplasia--a prospective study.
Murthy NS; Sardana S; Narang N; Agarwal SS; Sharma S; Das DK
Indian J Cancer; 1996 Mar; 33(1):24-30. PubMed ID: 9063015
[TBL] [Abstract][Full Text] [Related]
7. [Dysplasia and carcinoma in situ of the uterine cervix in pregnancy].
Pajtler M; Cugalj B; Milojković M; Makarović Z
Jugosl Ginekol Perinatol; 1990; 30(1-2):15-8. PubMed ID: 2214848
[TBL] [Abstract][Full Text] [Related]
8. Appraisal of the modalities used to evaluate an initial abnormal Papanicolaou smear.
Higgins RV; Hall JB; McGee JA; Laurent S; Alvarez RD; Partridge EE
Obstet Gynecol; 1994 Aug; 84(2):174-8. PubMed ID: 8041525
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the HPV L1 capsid protein in prognosis of mild and moderate dysplasia of the cervix uteri.
Stemberger-Papić S; Vrdoljak-Mozetic D; Ostojić DV; Rubesa-Mihaljević R; Manestar M
Coll Antropol; 2010 Jun; 34(2):419-23. PubMed ID: 20698112
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of cytological screening for cancers and precancerous lesions of the cervix].
Boman F; Duhamel A; Trinh QD; Deken V; Leroy JL; Beuscart R
Bull Cancer; 2003 Jul; 90(7):643-7. PubMed ID: 12957806
[TBL] [Abstract][Full Text] [Related]
11. Significance of subclassifying high-grade squamous intraepithelial lesions into moderate dysplasia/CIN II versus severe dysplasia/CIN III/CIS in the Bethesda System terminology.
Howell LP; Zhou H; Wu W; Davis R
Diagn Cytopathol; 2004 May; 30(5):362-6. PubMed ID: 15108239
[TBL] [Abstract][Full Text] [Related]
12. Visual inspection of the uterine cervix after the application of acetic acid in the detection of cervical carcinoma and its precursors.
Sankaranarayanan R; Wesley R; Somanathan T; Dhakad N; Shyamalakumary B; Amma NS; Parkin DM; Nair MK
Cancer; 1998 Nov; 83(10):2150-6. PubMed ID: 9827719
[TBL] [Abstract][Full Text] [Related]
13. From Papanicolaou to Bethesda: the rationale for a new cervical cytologic classification.
Kurman RJ; Malkasian GD; Sedlis A; Solomon D
Obstet Gynecol; 1991 May; 77(5):779-82. PubMed ID: 1849626
[TBL] [Abstract][Full Text] [Related]
14. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.
Liao SY; Stanbridge EJ
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):549-57. PubMed ID: 8827360
[TBL] [Abstract][Full Text] [Related]
15. [Cervix smears with mild atypia classified as Pap-class IIIA: results of a changed policy].
Doornewaard H; Woudt JM; Sie-Go DM; Kooijman CD
Ned Tijdschr Geneeskd; 1991 Sep; 135(36):1642-5. PubMed ID: 1922503
[TBL] [Abstract][Full Text] [Related]
16. Predicting absolute risk of CIN3 during post-colposcopic follow-up: results from the ASCUS-LSIL Triage Study (ALTS).
Walker JL; Wang SS; Schiffman M; Solomon D;
Am J Obstet Gynecol; 2006 Aug; 195(2):341-8. PubMed ID: 16890545
[TBL] [Abstract][Full Text] [Related]
17. Behavior of moderate cervical dysplasia during long-term follow-up.
Nasiell K; Nasiell M; Vaćlavinková V
Obstet Gynecol; 1983 May; 61(5):609-14. PubMed ID: 6835614
[TBL] [Abstract][Full Text] [Related]
18. Severe cervical glandular cell lesions and severe cervical combined lesions: predictive value of the papanicolaou smear.
van Aspert-van Erp AJ; Smedts FM; Vooijs GP
Cancer; 2004 Aug; 102(4):210-7. PubMed ID: 15368312
[TBL] [Abstract][Full Text] [Related]
19. Silver-stained nucleolar organizer regions in normal and dysplastic cervical lesions: correlation with DNA ploidy and S-phase fraction by flow cytometry.
Singh M; Prasad S; Kalra N; Singh U; Shukla Y
Oncology; 2006; 71(5-6):411-6. PubMed ID: 17785995
[TBL] [Abstract][Full Text] [Related]
20. [Long-term follow-up of women with first-time diagnosis of mild dysplasia detected by cytological examination of the cervix].
Knudsen A; Nielsen K; Sandahl P; Andersen ES
Ugeskr Laeger; 2003 May; 165(21):2183-7. PubMed ID: 12820504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
